SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-026638
Filing Date
2024-02-23
Accepted
2024-02-22 17:50:55
Documents
6
Effectiveness Date
2024-02-23

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm246827d1_s8.htm S-8 71548
2 EXHIBIT 4.4 tm246827d1_ex4-4.htm EX-4.4 151534
3 EXHIBIT 4.5 tm246827d1_ex4-5.htm EX-4.5 119494
4 EXHIBIT 5.1 tm246827d1_ex5-1.htm EX-5.1 9642
5 EXHIBIT 23.2 tm246827d1_ex23-2.htm EX-23.2 2588
6 EX-FILING FEES tm246827d1_ex-filingfees.htm EX-FILING FEES 10297
  Complete submission text file 0001104659-24-026638.txt   366120
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277293 | Film No.: 24666431
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)